2025. Placebo-controlled trials on the safety and efficacy of tiotropium bromide in patients with chronic obstructive pulmonary disease and bronchitis. International Journal of Life Sciences Biotechnology and Pharma Sciences. 21, 2 (Jun. 2025), 10–22.